The worldʼs leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its corporate mission is to enable everyone around the world to access lenses that meet his or her unique vision requirements. To support this mission, the Company allocates more than €150 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Essilorʼs flagship brands are Varilux®, Crizal®, Transitions, Definity®, Xperio®, OptifogTM, Foster Grant®, Bolon® and Costa®. It also develops and markets equipment, instruments and services for eyecare professionals. It operates in some 100 countries with 28 plants, more than 450 prescription laboratories and edging facilities, as well as several research and innovation centers around the world.
Closing share price
|Acquired Company||Date||Deal Size|
|Luxottica||January 16, 2017||$24 B|